Alexander Mischnik
Biographic Data
| ID | 7788094 |
|---|---|
| NAME | Alexander Mischnik |
| GIVEN NAMES | Alexander |
| FAMILY NAME | Mischnik |
| SIGNATURE | MISCHNIK A |
| AFFILIATIONS | Technical University of Applied Sciences Lübeck |
| ORCID | 0000-0003-2326-4132 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Spreading of Sars-CoV-2 among adult asylum seekers in refugee community shelters in Lübeck, Germany between 2020 and 2022
Refugees residing in shared accommodations represent a vulnerable group for SARS-CoV-2 infection and transmission. This increased vulnerability does not diminish over time. Initial doubts regarding vaccination are higher among refugees. While this reservation can be overcome, awareness work is paramount and has to start anew with any new refugee wave
Protocol of the Luebeck longitudinal investigation of Sars-CoV-2 infection (Elisa) study – a prospective population-based cohort study
DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00023418 , Registered on 28 October 2020
Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After Sars-CoV-2 Infection
Characterization of the naturally acquired B and T cell immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is important for the development of public health and vaccination strategies to manage the burden of COVID-19 disease. We conducted a prospective, cross-sectional analysis in COVID-19 recovered patients at various time points over a 10-month period in order to investigate how circulating antibody levels and inte…
Antibody Profiling of Covid-19 Patients in an Urban Low-Incidence Region in Northern Germany
A vast majority of COVID-19 cases present with mild or moderate symptoms. The study region is in an urban and well-defined environment in a low-incidence region in Northern Germany. In the present study, we explored the dynamics of the antibody response with respect to onset, level and duration in patients with confirmed SARS-CoV-2 infection. Anti-SARS-CoV-2 IgG and IgA were detected by automated enzyme-linked immunosorbent assay (ELISA) of SARS-…
No prominent works on this page.
Antibody Profiling of Covid-19 Patients in an Urban Low-Incidence Region in Northern Germany
A vast majority of COVID-19 cases present with mild or moderate symptoms. The study region is in an urban and well-defined environment in a low-incidence region in Northern Germany. In the present study, we explored the dynamics of the antibody response with respect to onset, level and duration in patients with confirmed SARS-CoV-2 infection. Anti-SARS-CoV-2 IgG and IgA were detected by automated enzyme-linked immunosorbent assay (ELISA) of SARS-…
Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After Sars-CoV-2 Infection
Characterization of the naturally acquired B and T cell immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is important for the development of public health and vaccination strategies to manage the burden of COVID-19 disease. We conducted a prospective, cross-sectional analysis in COVID-19 recovered patients at various time points over a 10-month period in order to investigate how circulating antibody levels and inte…
Protocol of the Luebeck longitudinal investigation of Sars-CoV-2 infection (Elisa) study – a prospective population-based cohort study
DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00023418 , Registered on 28 October 2020
Spreading of Sars-CoV-2 among adult asylum seekers in refugee community shelters in Lübeck, Germany between 2020 and 2022
Refugees residing in shared accommodations represent a vulnerable group for SARS-CoV-2 infection and transmission. This increased vulnerability does not diminish over time. Initial doubts regarding vaccination are higher among refugees. While this reservation can be overcome, awareness work is paramount and has to start anew with any new refugee wave
Immunology (4 works) · Medicine (4 works) · SARS-CoV-2 and COVID-19 Research (4 works) · Vaccination (4 works) · Antibody (3 works) · COVID-19 Clinical Research Studies (3 works) · Internal Medicine (3 works) · Cohort (2 works) · Cohort study (2 works) · Disease (2 works)